Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers

Frontiers Comparative Analysis of Microfluidics Thrombus Formation in Multiple Genetically Modified Mice: Link to Thrombosis and Hemostasis

PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers

Frontiers Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies

Frontiers Neutrophils in pancreatic cancer: Potential therapeutic targets

paraneoplastic syndrome - List of Frontiers' open access articles

P2Y12 Receptor Modulates Sepsis-Induced Inflammation

Immunological combination treatment holds the key to improving survival in pancreatic cancer

Frontiers Comparative Analysis of Microfluidics Thrombus Formation in Multiple Genetically Modified Mice: Link to Thrombosis and Hemostasis

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial - The

Cancer-associated venous thromboembolism

Loop Ana Luisa Palacios Acedo

The role of coagulation and platelets in colon cancer-associated thrombosis

Frontiers Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies